Guardian Pink-bismuth Cherry Tablet, Chewable
NDC Package 53041-022-49

11-digit billing NDC: 53041002249

Package Information

Guardian Pink-bismuth Cherry (bismuth subsalicylate) tablets is chew or dissolve in mouthadults and children 12 years and over: 2 tablets every 1/2 to 1 hour as neededdo not take more than 8 doses (16 tablets) in 24 hourschildren under 12 years: ask a doctordrink plenty of fluids to help prevent dehydration caused by diarrhea. This formulation utilizes a tablet, chewable delivery system. Marketed by Guardian Drug Company, this product is identified by NDC 53041-022 and is authorized under FDA application part335.

Identification & Billing

NDC Package Code
53041-022-49
Package Description
5 BLISTER PACK in 1 BOX / 6 TABLET, CHEWABLE in 1 BLISTER PACK
Product Code
11-Digit Billing Format
53041002249
RxNorm Crosswalk
RxCUI: 308761 - bismuth subsalicylate 262 MG Chewable Tablet

Clinical Specifications

Proprietary Name
Guardian Pink-bismuth Cherry
Non-Proprietary Name
Bismuth Subsalicylate
Substance Name
Bismuth Subsalicylate
Dosage Form
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Chew or dissolve in mouthadults and children 12 years and over: 2 tablets every 1/2 to 1 hour as neededdo not take more than 8 doses (16 tablets) in 24 hourschildren under 12 years: ask a doctordrink plenty of fluids to help prevent dehydration caused by diarrhea

Regulatory & Marketing

Labeler Name
Guardian Drug Company
Product Type
Human Otc Drug
FDA Application #
part335
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-04-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53041-022-49 identifies a specific commercial package of 5 blister pack in 1 box / 6 tablet, chewable in 1 blister pack of Guardian Pink-bismuth Cherry, a human over the counter drug labeled by Guardian Drug Company. This tablet, chewable is formulated for oral use and contains bismuth subsalicylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guardian Drug Company on December 04, 2023. The current certification is valid through December 31, 2026.

How is this Guardian Drug Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53041002249. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
53041-022-49
11-Digit CMS (5-4-2)
53041-0022-49

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.